Exosome-derived miR-196b-5p facilitates intercellular interaction in infantile hemangioma via down-regulating CDKN1B

Background Though infantile hemangioma (IH) is a common benign vascular tumor, its pathogenesis remains unclear. This study explored the function of hemangioma-derived stem cells (HemSCs) derived exosomes, which exerted an intercellular effect on hemangioma-derived endothelial cells (HemECs). Methods First, HemSCs and HemECs were extracted and cultured. HemSCs derived exosomes (HemSCs-exos) were harvested. miRNA sequencing and target prediction were used to explore differentially expressed miRNAs and potential binding targets. After HemECs were co-cultured with HemSCs-exos, a series of in vitro assays were then performed including cell counting kit-8 (CCK-8) assay, cell apoptosis assay, cell cycle assay and tube formation assay to evaluate proliferation, angiogenesis abilities, etc. qRT-PCR and Western blot were conducted to detect the expression level of target genes and proteins. Results After co-culturing with HemSCs-exos, proliferation, and angiogenesis abilities of HemECs were enhanced, while apoptosis and cell cycle arrest rate were decreased. MiR-196b-5p was observed to be significantly highly expressed in HemSCs-exos. CDKN1B was identified as the binding target of miR-196b-5p. HemECs’ proliferation and angiogenesis abilities were elevated when co-cultured with exosomes from HemSCs transfected with miR-196b-5p mimic. In addition, apoptosis rate declined, and lower cells were arrested in G0/G1 phases. Cyclin E, bcl-2 were significantly highly expressed, whereas p27, Bax expression were significantly down-regulated. The positive effect of miR-196b-5p in HemSCs-exos was dramatically reversed when HemECs were transfected with oe-CDKN1B. Conclusions The current study found a novel intercellular interaction between IH cells. Briefly, exosome-derived miRNA-196b-5p in HemSCs could facilitate proliferation and angiogenesis abilities, and attenuate apoptosis and cell cycle repression rate of HemECs by directly binding with CDKN1B.

[1]  Xin-hua Liang,et al.  OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway , 2020, Cancer Immunology, Immunotherapy.

[2]  Cheng-Chia Yu,et al.  Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development , 2020, International journal of nanomedicine.

[3]  Qifu Li,et al.  miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes , 2020, BMJ open diabetes research & care.

[4]  K. Harikumar,et al.  p27 as a Transcriptional Regulator: New Roles in Development and Cancer , 2020, Cancer Research.

[5]  Zhaoyu Liu,et al.  MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5 , 2020, Cancer Cell International.

[6]  Jisong Zhang,et al.  Exosome-Derived miR-486-5p Regulates Cell Cycle, Proliferation and Metastasis in Lung Adenocarcinoma via Targeting NEK2 , 2020, Frontiers in Bioengineering and Biotechnology.

[7]  Zhen-ning Wang,et al.  Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN , 2020, Frontiers in Oncology.

[8]  Jia-ming Huang,et al.  CDKN1B Mediates Apoptosis of Neuronal Cells and Inflammation Induced by Oxyhemoglobin via miR-502-5p After Subarachnoid Hemorrhage , 2020, Journal of Molecular Neuroscience.

[9]  C. Croce,et al.  miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer , 2020, Proceedings of the National Academy of Sciences.

[10]  Binbin Cui,et al.  Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by downregulating DLC-1 expression. , 2020, Clinical science.

[11]  Hang Zhou,et al.  Exosomal miR-199a-5p derived from endothelial cells attenuates apoptosis and inflammation in neural cells by inhibiting endoplasmic reticulum stress , 2020, Brain Research.

[12]  F. Sánchez-Margallo,et al.  Unraveling the Molecular Signature of Extracellular Vesicles From Endometrial-Derived Mesenchymal Stem Cells: Potential Modulatory Effects and Therapeutic Applications , 2019, Front. Bioeng. Biotechnol..

[13]  Jianghui Zhao,et al.  MicroRNA-222-3p participates in the development of oral squamous cell carcinoma by targeting CDKN1B. , 2019, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[14]  Jun Liu,et al.  Up-regulated Linc00472 suppresses development of lung cancer cell via inhibition of MiR-196b-5p. , 2019, Bioscience, biotechnology, and biochemistry.

[15]  Zhen-bo Feng,et al.  Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism , 2019, Journal of Cancer.

[16]  Chunyu Jiang,et al.  Endothelial progenitor cell-derived exosomes facilitate vascular endothelial cell repair through shuttling miR-21-5p to modulate Thrombospondin-1 expression. , 2019, Clinical science.

[17]  C. Kenific,et al.  Exosome-Mediated Metastasis: Communication from a Distance. , 2019, Developmental cell.

[18]  Dylan T Burnette,et al.  Reassessment of Exosome Composition , 2019, Cell.

[19]  Jingxia Li,et al.  Autophagy-mediated Mir6981 degradation exhibits CDKN1B promotion of PHLPP1 protein translation , 2019, Autophagy.

[20]  D. Geng,et al.  MicroRNA‐221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27 , 2019, Journal of cellular biochemistry.

[21]  Yanyan Jiang,et al.  MiR-187-3p Enhances Propranolol Sensitivity of Hemangioma Stem Cells. , 2019, Cell structure and function.

[22]  Ji-Yuan Liu,et al.  Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[23]  Hongfei Wu,et al.  miR-501 promotes hemangioma progression by targeting HOXD10. , 2019, American journal of translational research.

[24]  Xu Wang,et al.  Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5 , 2019, Genome Biology.

[25]  Shi-gang Lv,et al.  Exosomes secreted by HUVECs attenuate hypoxia/reoxygenation-induced apoptosis in neural cells by suppressing miR-21-3p. , 2018, American journal of translational research.

[26]  D. Towler,et al.  An Endothelial-to-Adipocyte Extracellular Vesicle Axis Governed by Metabolic State , 2018, Cell.

[27]  C. Flohr,et al.  Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines , 2018, The British journal of dermatology.

[28]  T. Ma,et al.  Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization , 2018, Stem Cell Research & Therapy.

[29]  Zhonghua Ma,et al.  MiR‐616‐3p modulates cell proliferation and migration through targeting tissue factor pathway inhibitor 2 in preeclampsia , 2018, Cell proliferation.

[30]  L. Dimeglio,et al.  Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes , 2018, Diabetologia.

[31]  Yang Gao,et al.  miR-181a-5p suppresses invasion and migration of HTR-8/SVneo cells by directly targeting IGF2BP2 , 2018, Cell Death & Disease.

[32]  E. Letsiou,et al.  Endothelial Extracellular Vesicles in Pulmonary Function and Disease. , 2018, Current topics in membranes.

[33]  Naikhoba C. O. Munabi,et al.  NOTCH3 regulates stem-to-mural cell differentiation in infantile hemangioma. , 2017, JCI insight.

[34]  Xiaoqing Wang,et al.  Human Endothelial Progenitor Cell-Derived Exosomes Increase Proliferation and Angiogenesis in Cardiac Fibroblasts by Promoting the Mesenchymal-Endothelial Transition and Reducing High Mobility Group Box 1 Protein B1 Expression. , 2017, DNA and cell biology.

[35]  R. Khokha,et al.  Metalloproteinases in extracellular vesicles. , 2017, Biochimica et biophysica acta. Molecular cell research.

[36]  Fengming Yang,et al.  Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts , 2017, Molecular Cancer.

[37]  Alan W. Stitt,et al.  MicroRNA‐containing extracellular vesicles released from endothelial colony‐forming cells modulate angiogenesis during ischaemic retinopathy , 2017, Journal of cellular and molecular medicine.

[38]  R. Hajjar,et al.  Angiogenic Mechanisms of Human CD34+ Stem Cell Exosomes in the Repair of Ischemic Hindlimb , 2017, Circulation research.

[39]  Peng Li,et al.  Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway. , 2017, International journal of molecular medicine.

[40]  E. Herter,et al.  Non-Coding RNAs: New Players in Skin Wound Healing , 2017, Advances in wound care.

[41]  Guo-Yuan Yang,et al.  Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke , 2017, Front. Neurol..

[42]  L. Chiriboga,et al.  Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell , 2016, Scientific Reports.

[43]  Hong-Jian Zhu,et al.  Extracellular vesicle isolation and characterization: toward clinical application. , 2016, The Journal of clinical investigation.

[44]  Clotilde Théry,et al.  Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.

[45]  P. Li,et al.  Propranolol induces regression of hemangioma cells via the down‐regulation of the PI3K/Akt/eNOS/VEGF pathway , 2015, Pediatric blood & cancer.

[46]  Mary Wu Chang,et al.  A Randomized, Controlled Trial of Oral Propranolol for Infantile Hemangioma , 2015 .

[47]  J. Mulliken,et al.  Glucose Transporter 1‐Positive Endothelial Cells in Infantile Hemangioma Exhibit Features of Facultative Stem Cells , 2015, Stem cells.

[48]  J. Mulliken,et al.  E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma. , 2012, The American journal of pathology.

[49]  N. Chan,et al.  Evolution of hemangioma endothelium. , 2012, Experimental and molecular pathology.

[50]  L. Zhu,et al.  miR-221 is required for endothelial tip cell behaviors during vascular development. , 2012, Developmental cell.

[51]  J. Slingerland,et al.  p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies , 2010, Clinical Cancer Research.

[52]  Wancai Yang,et al.  p27 Suppresses Arsenite-induced Hsp27/Hsp70 Expression through Inhibiting JNK2/c-Jun- and HSF-1-dependent Pathways* , 2010, The Journal of Biological Chemistry.

[53]  E. Boscolo,et al.  Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. , 2010, The New England journal of medicine.

[54]  S. Polster,et al.  Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27 , 2010, Molecular and Cellular Biochemistry.

[55]  Xue Leng,et al.  Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. , 2009, Biochemical and biophysical research communications.

[56]  E. Boscolo,et al.  Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma , 2008, Nature Medicine.

[57]  E. Boscolo,et al.  Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. , 2008, The Journal of clinical investigation.

[58]  Ludger Hengst,et al.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy , 2008, Nature Reviews Cancer.

[59]  Gordon B. Mills,et al.  The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis , 2007, Nature Cell Biology.

[60]  E. Boscolo,et al.  Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. , 2006, Blood.

[61]  Ekaterini Panopoulou,et al.  Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms. , 2005, Cancer research.